En español | You may think of longevity as just more time to struggle with the diseases and disabilities that can come with getting older, but studies show that people who do live very long lives remain free from diseases and disabilities until quite late in life. Now Boston University researchers have discovered some of the genetic quirks that appear to delay the arrival of age-related conditions in people who live to 100 and beyond.
The team performed genetic tests on a large group of centenarians to look for those quirks, called genetic variants or single-nucleotide polymorphisms (SNPs), that are more common in centenarians than others. They then used a novel statistical approach to analyze the data and produce a “genetic signature”—made up of 150 SNPs and involving about 70 genes—that is predictive of living to 100, the team reported July 1 in the journal Science.
People’s lifestyle and environment play a very big role in how long they live. But pinpointing the SNPs common to centenarians is one step toward the very complex process of understanding how genes pave the way to truly golden years, the researchers say. It may also lead to a test that will tell people if they have what it takes genetically to live past 100.
Discovering the genes
The team conducted the New England Centenarian Study at Boston Medical Center by comparing the genetic profiles of about 800 individuals, ages 95 to 119, with a group of noncentenarians. Of the centenarians, 85 percent were women and all were Caucasian. The group is studying other ethnicities but doesn’t yet have results available.
The team found that 90 percent of the centenarian group could be subdivided into 19 subgroups or clusters.
Specific clusters shared unique characteristics, such as when or whether they got different age-related diseases. Although men and women had similar genetic signatures, the men were generally healthier than the women, says coauthor Thomas Perls, M.D., director of the New England Centenarian Study.
They beat the risks
Despite being what Perls calls “models of healthy aging,” centenarians had a similar number—compared with the noncentenarians—of the genetic variants known to increase a person’s risk of disease, the team found.
“This suggests that what makes these people live very long lives is not a lack of genetic predisposition to disease but rather an enrichment of [genetic variants] that may be protective and may even cancel the negative effect of disease associated variants,” says coauthor and biostatician Paola Sebastiani of Boston University School of Public Health.
Whether these genetic charms can be bottled and sold is another question. “I look at the complexity of this [genetic longevity] puzzle and feel very strongly that this will not lead to treatments that will get a lot of people to become centenarians,” Perls says. However, he is optimistic that understanding centenarians’ genetic traits that postpone the onset of age-related diseases, such as dementia, will lead to strategies for delaying the conditions in others.
Longevity tests for all?
The genetic signature that the Boston team found could conceivably be used to predict whether anyone has the genetic make-up to live past 100, says Perls. They are making their computer program available to other researchers and do not plan on patenting it. But he doesn’t think it should be made available to the public anytime soon.
A government-funded scientist, Perls suspects that companies will probably try to market a longevity test for consumers. But he warns that it’s important to understand what consumers, insurance companies and others may end up doing with this information.
“What would you do if you are told you absolutely don’t have the signature for longevity—would you go do a lot of risk taking behaviors … or does it give you impetus to take all the more better care of yourself?” he asks.